Skip to main content
. 2021 Sep 27;11:19159. doi: 10.1038/s41598-021-98565-w

Table 3.

Age-, sex-, and race-adjusted odds ratios [OR (95% CI)] for the association of risk factors with peripheral neuropathy in US adults aged 40–69 and ≥ 70 years (NHANES, 1999–2004) and ARIC participants aged ≥ 70 years (Visit 6, 2016–2017).

Aged 40–69 years Aged ≥ 70 years
US adults (NHANES)
OR (95% CI)
US adults (NHANES)
OR (95% CI)
ARIC (Visit 6)
OR (95% CI)
Age in years
40–49 1 (Ref)
50–59 1.81 (1.38–2.37)
60–69 3.20 (2.38–4.31)
70–74 1 (Ref) 1 (Ref)
75–79 1.47 (1.06–2.04) 1.35 (1.06–1.71)
≥ 80 2.04 (1.51–2.75) 2.38 (1.87–3.02)
Sex
Female 1 (Ref) 1 (Ref) 1 (Ref)
Male 2.36 (1.94–2.86) 2.22 (1.79–2.75) 2.75 (2.37–3.20)
Race
White 1 (Ref) 1 (Ref) 1 (Ref)
Black 1.49 (1.20–1.85) 1.63 (1.11–2.39) 1.32 (1.09–1.58)
Education
College and above 1 (Ref) 1 (Ref) 1 (Ref)
High school or vocational school 1.35 (1.01–1.81) 1.02 (0.71–1.46) 1.02 (0.87–1.19)
Less than high school 1.81 (1.26–2.58) 1.14 (0.78–1.67) 1.60 (1.25–2.03)
Diabetes status
Normal 1 (Ref) 1 (Ref) 1 (Ref)
Pre-diabetes 1.53 (1.01–2.30) 0.89 (0.64–1.22) 1.19 (0.99–1.44)
Diabetes (< 10 years duration) 1.82 (1.07–3.10) 1.50 (1.00–2.27) 1.32 (1.09–1.60)
Diabetes (≥ 10 years duration) 5.26 (3.27–8.46) 2.17 (1.33–3.54) 1.68 (1.29–2.20)
Body mass index, kg/m2
0–24.9 1 (Ref) 1 (Ref) 1 (Ref)
25–29.9 1.14 (0.77–1.69) 1.22 (0.93–1.61) 1.05 (0.87–1.27)
≥ 30 1.74 (1.23–2.48) 1.87 (1.39–2.51) 1.58 (1.30–1.92)
Sex-specific height quartile
Q1 1 (Ref) 1 (Ref) 1 (Ref)
Q2 0.99 (0.68–1.44) 1.43 (1.11–1.85) 1.02 (0.81–1.28)
Q3 1.43 (1.05–1.93) 1.74 (1.27–2.39) 1.46 (1.17–1.81)
Q4 2.15 (1.54–3.00) 2.91 (2.04–4.14) 2.36 (1.91–2.91)
Smoking status
Never 1 (Ref) 1 (Ref) 1 (Ref)
Former 0.95 (0.70–1.30) 0.99 (0.74–1.31) 0.95 (0.81–1.11)
Current 1.17 (0.86–1.59) 0.45 (0.26–0.80) 1.05 (0.77–1.42)
Drinking status
Current light/moderate drinker 1 (Ref) 1 (Ref) 1 (Ref)
Current heavier drinker 1.28 (0.93–1.76) 0.89 (0.60–1.32) 0.80 (0.55–1.17)
Former 1.41 (1.07–1.84) 1.31 (0.93–1.84) 1.11 (0.93–1.33)
Never 1.74 (1.21–2.49) 1.56 (1.06–2.30) 1.24 (1.01–1.52)
Prevalent cardiovascular disease
No 1 (Ref) 1 (Ref) 1 (Ref)
Yes 1.37 (0.90–2.08) 1.39 (0.96–2.00) 1.20 (1.00–1.44)
Hypertension
No 1 (Ref) 1 (Ref) 1 (Ref)
Yes 1.30 (1.02–1.67) 1.07 (0.86–1.32) 1.27 (1.03–1.58)
Hypercholesterolemia
No 1 (Ref) 1 (Ref) 1 (Ref)
Yes 1.12 (0.84–1.48) 0.74 (0.59–0.92) 1.02 (0.88–1.19)
Prevalent chronic kidney disease
No 1 (Ref) 1 (Ref) 1 (Ref)
Yes 1.71 (1.25–2.33) 1.17 (0.84–1.62) 1.35 (1.16–1.57)
Peripheral artery diseasea
No 1 (Ref) 1 (Ref) 1 (Ref)
Yes 2.02 (1.31–3.10) 0.99 (0.69–1.42) 1.64 (1.16–2.30)
Any cancerb
No 1 (Ref) 1 (Ref) 1 (Ref)
Yes 1.21 (0.79–1.84) 1.19 (0.88–1.59) 1.21 (0.98–1.48)

aOdds ratios are among participants who were not missing data for peripheral artery disease: N = 3215 in NHANES aged 40–69 years, N = 1204 in NHANES aged ≥ 70 years, and N = 2971 in ARIC visit 6.

bOdds ratio for ARIC is among participants who were not missing cancer status in ARIC visit 6, N = 3136.